Treatment of H. pylori Infection: A Review

Title: Treatment of H. pylori Infection: A Review

Volume: 12 Issue: 4

Author(s): Marcello Candelli, Enrico C. Nista, Emilia Carloni, Giulia Pignataro, Maria Assonta Zocco, Alossia Cazzato, Cristiana Di Campli, Lucia Fini, Giovanni Gasbarrini and Antonio Gasbarrini

Affiliation:

Keywords: H. pylori Infection, pathogenic factor, anti-Helicobacter regimens, asymptomatic gastritis

Abstract: Helicobacter pylori infection has been indicated as the main pathogenic factor in the development of chronic gastritis, peptic ulcer disease, and gastric malignancies. Although the vast majority of infected subjects do not carry but a mild, asymptomatic gastritis, still there are some cases in which the eradication of the infection appears mandatory. This review addresses current anti-Helicobacter regimens and pharmacological resources, and highlights the pros and cons of each of them, according to the most recent and reliable clinical trials. Also, basic recommendations are given, regarding treatment choice in the event of the failure of a first or second line eradicating strategy, and about the implementation of standard regimens with newer antibacterial devices as probiotics.

Cite this article as:

Candelli Marcello, Nista C. Enrico, Carloni Emilia, Pignataro Giulia, Zocco Assonta Maria, Cazzato Alossia, Campli Di Cristiana, Fini Lucia, Gasbarrini Giovanni and Gasbarrini Antonio, Treatment of H. pylori Infection: A Review, Current Medicinal Chemistry 2005; 12 (4) . https://dx.doi.org/10.2174/0929867053363027